Deutsche Bank’s Zenas BioPharma ZBIO Stock Holding History

Deutsche Bank’s Portfolio ZBIO Stock Details ZBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$377K	Buy	19,266 +6,485	+51%	+$146K	﹤0.01%	2722
2025 Q4	$464K	Buy	12,781 +554	+5%	+$18.2K	﹤0.01%	2611
2025 Q3	$271K	Buy	12,227 +11,947	+4,267%	+$194K	﹤0.01%	2904
2025 Q2	$2.71K	Sell	280 -22,710	-99%	-$221K	﹤0.01%	3562
2025 Q1	$182K	Hold	22,990	–	–	﹤0.01%	2995
2024 Q4	$188K	Buy	+22,990	New	+$359K	﹤0.01%	3111

Other funds holding ZBIO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NVP Associates Menlo Park, California $176M AUM 208.78% 1-Year Est. Return

Deutsche Bank's ZBIO Position: Q1 2026 in Review

Deutsche Bank increased its Zenas BioPharma (ZBIO) stake by 51% in Q1 2026, buying an estimated $146K and bringing the position to 19,266 shares worth $377K. The position accounts for ﹤0.01% of the portfolio, ranked #2722.

Deutsche Bank first reported a position in ZBIO in Q4 2024 and has held it in 6 quarters since. The position peaked at $464K in Q4 2025. 139 funds tracked by Wall St. Rank hold ZBIO as of Q1 2026.

Deutsche Bank held 19,266 shares of Zenas BioPharma worth $377K as of Q1 2026.
Deutsche Bank bought 6,485 Zenas BioPharma shares in Q1 2026, an estimated $146K.
Zenas BioPharma made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #2722 holding.
Deutsche Bank first reported a position in Zenas BioPharma in Q4 2024 and has held it in 6 quarters since.
Deutsche Bank's Zenas BioPharma position peaked at $464K in Q4 2025.
139 funds tracked by Wall St. Rank held Zenas BioPharma as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.